MAPT and Alzheimer disease: Experimental evidence supports the hypothesis that some flavonoids may be beneficial in AD models, in part by supporting antioxidant mechanisms, in part by interfering with the generation and assembly of Aβ peptides in neurotoxic oligomeric aggregates and also by reducing the aggregation of tau [280].